I am Umesh Chhikara, a self-styled real-life researcher. My case studies don’t come from sterile labs; they’re drawn from the messy, dynamic reality of people’s lives—athletes, professionals, everyday individuals navigating their health in real environments.

Note: I steer clear of giving medical advice, yet my work has guided countless clients away from unnecessary medications through sharp analysis and a holistic lens.

In the below studies: No doctor or expert would dispute that, without my scrutiny, the individuals in the cases below would likely be on statins or metformin for life—drugs with real risks like muscle pain or metabolic disruption. For me, these aren’t just success stories; they’re live experiments teaching profound lessons about health, variability, and the flaws in our system – urgency for pharma intervention.

Through my podcast and writings, I share these insights to empower you. The observations and arguments here are mine alone—not medical advice, but not mere blogging either. These are real lives at stake, where a single blood test can mislead catastrophically. My process is simple yet rigorous: I start with a client’s blood report, simulate the data to form hypotheses, request additional tests if needed, and guide them to doctors for any red flags. I focus on interpreting what’s going wrong, suggesting nutritional shifts with clear reasoning, adding supplements only when necessary, and retesting in 6-8 weeks based on the case. Let’s dive into three fascinating case studies from my practice that expose how blood test variability can lead to life-altering missteps.

One client, a teetotaler and light eater, showed remarkable liver health gains—SGOT dropping from 50.2 to 34, SGPT from 84 to 45—paired with an HbA1c of 5.1%, signaling strong glucose metabolism. Yet triglycerides (TGs) remained stuck at 293, defying what metabolic science typically predicts. A doctor might have rushed to prescribe statins, but my insistence on a retest at a different lab normalized the numbers a bit (TG @200). Instead of pushing him to a doctor who was prescribing him statins, I asked him to do a CT angiogram instead and then discuss his case with the doctor. A zero-score CT angiogram (no artery buildup) confirmed no cardiovascular risk. Without my push for retesting, this client could have been on unneeded drugs indefinitely.

Result: He saved on pharma intervention both for fatty liver and cholesterol.

Another case involved a 60-year-old woman with high B12 levels (1135 pg/mL) from supplements. Her initial report showed HbA1c at 6.1%—flagging pre-diabetes—despite normal fasting glucose (80), low uric acid (4.9), and excellent lipids: TGs at 58, HDL at 72, LDL at 170, total cholesterol at 254. A retest days later shifted HbA1c to 5.8%, lowered B12 significantly, dropped LDL to 150, and total cholesterol to 235, with TGs and HDL steady. A zero CT angiogram confirmed low risk. The first report could have triggered metformin and statins for life, but my approach—considering genetics and potential imbalances from excess supplements (like uric acid spikes in high-protein diets)—revealed this as variability, not disease. This nuanced perspective, rare in standard practice, saved her from a pharmaceutical path.

Result: She saved on pharma intervention both again for diabetes & PCSk 9 inhibitors.

My own case at 51 further illustrates the point. With near-zero inflammation (CRP at 0.2 – consider is ZERO because I train regularly), HbA1c at 5.1%, liver enzymes around 22, testosterone over 800, 9.5% body fat, and a VO2 max of 55-65, my metrics rival a fit 20-something. Yet cholesterol fluctuated wildly: total cholesterol from 204 to 214, LDL steady at ~146, TGs from 173 to 115, HDL from 39 to 46, with prior tests showing TGs as low as 70. Genetics (echoing my father’s healthy longevity to 84) and athletic variability from training explain this, but a doctor might push statins based on LDL alone. My retests and contextual analysis prevented that trap.

These cases underscore a critical flaw: blood tests, treated as unerring truth, can mislead due to lab errors (like machine miscalibration) or biological swings (from stress, hormones, or diet). The stakes are high—lifelong medications with side effects, prescribed without a second glance. My unique lens, blending evolutionary biology, training impacts, and cultural factors like Indian dietary habits, reveals what standard protocols miss. These aren’t just numbers; they’re snapshots demanding scrutiny.

Here’s your call to action: 
– **Insist on Retests**: If results don’t match your health or lifestyle, demand immediate rechecks at another lab. Doctors may not suggest it, but it’s your shield against unwarranted drugs. 
– **Seek Context**: Question genetics, supplements, or daily variability. Ask questions like – “If my CT angiogram is zero, TGs are low, and HbA1c is solid, are statins necessary?” 
– **Engage Doctors Smartly**: Share high markers but challenge recommendations with knowledge. Your health demands informed dialogue. 

As a real-life researcher, my mission is to empower you to question the status quo. Don’t let a flawed snapshot dictate your health’s future.